SHS Gesellschaft für Beteiligungsmanagement (SHS), a Tuebingen, Germany-based independent private equity firm, has started raising capital for its fifth fund.
With a planned volume of €150m, the fund will invest in companies focusing on the global markets for medical technology and diagnostics. The targeted investments should have strong management teams as well as innovative products or business models. Their offer should cover yet unmet medical needs and thus have strong national and international growth potential.
SHS invests in companies with marketable products that target growth or plan to permeate new markets and supports its portfolio companies through years of experience and market knowledge and with its extensive network of contacts and partnerships.
Founded in 1993, the firm is currently investing out of its fourth venture capital and private equity fund (SHS IV) in young, high-growth MedTech/Life Sciences companies as well as small buyouts and growth financings of established companies from these sectors.